The cancer cachexia market is expected to witness an expansion across the 7MM, driven by the introduction of innovative therapies, ponsegromab (PF-06946860), S-pindolol benzoate (ACM-001.1), and TCMCB07, among others. Additionally, the rising prevalence of cancer cachexia, driven by...
Cancer Cachexia Market Anticipates Impressive Growth Trajectory at a CAGR of 8.9% During the Forecast Period (2025-2034) | DelveInsight
Seeking Alpha / 11 hours ago 4 Views
Comments